134 related articles for article (PubMed ID: 9430355)
41. Metabolism of asialoglycoproteins in cultured rat hepatocytes: evidence for receptor mediated uptake and degradation which is not feed-back regulated.
Drevon CA; Tolleshaug H; Carlander B; Berg T
Int J Biochem; 1983; 15(6):827-33. PubMed ID: 6190689
[TBL] [Abstract][Full Text] [Related]
42. Binding and internalization of asialo-glycoproteins by isolated rat hepatocytes.
Tolleshaug H
Int J Biochem; 1981; 13(1):45-51. PubMed ID: 6162684
[No Abstract] [Full Text] [Related]
43. Nonenzymatic glycosylation of poly-L-lysine: a new tool for targeted gene delivery.
Martinez-Fong D; Mullersman JE; Purchio AF; Armendariz-Borunda J; Martinez-Hernandez A
Hepatology; 1994 Dec; 20(6):1602-8. PubMed ID: 7982661
[TBL] [Abstract][Full Text] [Related]
44. Antiviral activity of a conjugate of adenine-9-beta-D-arabinofuranoside 5'-monophosphate and a 9 kDa fragment of arabinogalactan.
Josephson L; Rutkowski JV; Paul K; Frigo T; Korba BE; Tennant B; Groman EV
Antivir Ther; 1996 Aug; 1(3):147-56. PubMed ID: 11322248
[TBL] [Abstract][Full Text] [Related]
45. Protein/oligonucleotide conjugates as a cell specific PNA carrier.
Obara K; Ishihara T; Akaike T; Maruyama A
Nucleic Acids Res Suppl; 2001; (1):217-8. PubMed ID: 12836342
[TBL] [Abstract][Full Text] [Related]
46. Hepatocyte targeting of adenine-9-beta-D-arabinofuranoside 5' -monophosphate (ara-AMP) coupled to lactosaminated albumin.
Fiume L; Busi C; Mattioli A; Balboni PG; Barbanti-Brodano G
FEBS Lett; 1981 Jul; 129(2):261-4. PubMed ID: 6169548
[No Abstract] [Full Text] [Related]
47. Recurrence of hepatitis B in liver transplants treated with antiviral therapy.
Marzano A; Debernardi-Venon W; Smedile A; Brunetto MR; Torrani Cerenzia MR; Actis GC; Zamboni F; Ghisetti V; Piantino P; David E; Salizzoni M; Rizzetto M
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):77-81. PubMed ID: 9615271
[TBL] [Abstract][Full Text] [Related]
48. Floxuridine coupling with lactosaminated human albumin to increase drug efficacy on liver micrometastases.
Di Stefano G; Busi C; Fiume L
Dig Liver Dis; 2002 Jun; 34(6):439-46. PubMed ID: 12132792
[TBL] [Abstract][Full Text] [Related]
49. Chylomicron remnant and asialoglycoprotein metabolism are independent.
Cooper AD; Coleman D
Lipids; 1985 Oct; 20(10):664-7. PubMed ID: 2414633
[TBL] [Abstract][Full Text] [Related]
50. Doxorubicin coupled to lactosaminated human albumin remains confined within mouse liver cells after the intracellular release from the carrier.
Di Stefano G; Kratz F; Lanza M; Fiume L
Dig Liver Dis; 2003 Jun; 35(6):428-33. PubMed ID: 12868680
[TBL] [Abstract][Full Text] [Related]
51. Interaction between desialylated hepatitis B virus and asialoglycoprotein receptor on hepatocytes may be indispensable for viral binding and entry.
Owada T; Matsubayashi K; Sakata H; Ihara H; Sato S; Ikebuchi K; Kato T; Azuma H; Ikeda H
J Viral Hepat; 2006 Jan; 13(1):11-8. PubMed ID: 16364077
[TBL] [Abstract][Full Text] [Related]
52. Intracellular segregation of asialo-transferrin and asialo-fetuin following uptake by the same receptor system in suspended hepatocytes.
Tolleshaug H
Biochim Biophys Acta; 1984 Mar; 803(3):182-90. PubMed ID: 6200144
[TBL] [Abstract][Full Text] [Related]
53. Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells.
Maitani Y; Kawano K; Yamada K; Nagai T; Takayama K
J Control Release; 2001 Aug; 75(3):381-9. PubMed ID: 11489324
[TBL] [Abstract][Full Text] [Related]
54. The pathogenesis of vacuoles produced in rat and mouse liver cells by a conjugate of adenine arabinoside monophosphate with lactosaminated albumin.
Fiume L; Betts CM; Busi C; Corzani S; Derenzini M; Di Stefano G; Mattioli A
J Hepatol; 1992 Jul; 15(3):314-22. PubMed ID: 1447497
[TBL] [Abstract][Full Text] [Related]
55. Conjugates of 9-beta-D-arabinofuranosyladenine 5'-monophosphate (ara-AMP) with lactosaminated albumin. Characterization of the drug-carrier bonds.
Fiume L; Bassi B; Bongini A
Pharm Acta Helv; 1988; 63(4-5):137-9. PubMed ID: 2464835
[No Abstract] [Full Text] [Related]
56. Targeting of antiviral drugs bound to protein carriers.
Fiume L; Busi C; Mattioli A; Spinosa G
Crit Rev Ther Drug Carrier Syst; 1988; 4(4):265-84. PubMed ID: 3289759
[TBL] [Abstract][Full Text] [Related]
57. Uptake of lactosylated low-density lipoprotein by galactose-specific receptors in rat liver.
Bijsterbosch MK; Van Berkel TJ
Biochem J; 1990 Aug; 270(1):233-9. PubMed ID: 1697748
[TBL] [Abstract][Full Text] [Related]
58. Ligand size is a major determinant of high-affinity binding of fucose- and galactose-exposing (lipo)proteins by the hepatic fucose receptor.
Biessen EA; Bakkeren HF; Beuting DM; Kuiper J; Van Berkel TJ
Biochem J; 1994 Apr; 299 ( Pt 1)(Pt 1):291-6. PubMed ID: 8166653
[TBL] [Abstract][Full Text] [Related]
59. Specific uptake of asialofetuin-tacked liposomes encapsulating interferon-gamma by human hepatoma cells and its inhibitory effect on hepatitis B virus replication.
Ishihara H; Hayashi Y; Hara T; Aramaki Y; Tsuchiya S; Koike K
Biochem Biophys Res Commun; 1991 Jan; 174(2):839-45. PubMed ID: 1704230
[TBL] [Abstract][Full Text] [Related]
60. Enhanced accumulation of ribavirin and its metabolites in liver versus erythrocytes in mice administered with the liver targeted drug.
Di Stefano G; Bignamini A; Busi C; Colonna FP; Fiume L
Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):420-6. PubMed ID: 9494851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
